FDA approves new strength of Lupin antibiotic

BALTIMORE — The Food and Drug Administration has approved a new dosage of an antibiotic drug made by Lupin Pharmaceuticals, Lupin said Tuesday.



The Mumbai, India-based drug maker announced the approval of Suprax (cefixime) capsules in the 400-mg strength and plans to start shipping the drug "in the near future." The new approval adds to existing suspensions containing 100 mg per 5 mL and 200 mg per 5 mL.



The drug is used to treat infections such as pneumonia, gonorrhea and others.

Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.